| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |